DELRAY BEACH, Fla., Dec. 22, 2004 (PRIMEZONE) -- Hard to Treat Diseases, Incorporated (HTTD) (Pink Sheets:HTDS) Announces Status of Oklahoma (State) and Florida (Federal) Litigation:
On December 10, 2004, The Oklahoma Judge Denied Shinn Capital Group, Inc. et al.'s Motion for New Trial
On November 2, 2004, the District Court of Oklahoma entered an Order dismissing the Second Amended Petition of Shinn Capital Group, Inc. et al. against Hard to Treat Diseases, Inc., a Florida Corporation, allowing Shinn Capital Group, Inc. et al. to proceed in the pending Florida litigation. A copy of the Judge's Order to Dismiss can be viewed on our website at: http://www.htdsotc.com
On November 15, 2004, Shinn Capital Group, Inc. et al. filed a Motion for New Trial before the Oklahoma court against Hard to Treat Diseases, Inc., a Florida Corporation seeking to have the court reconsider its ruling dismissing the case.
On December 10, 2004, Judge Carolyn Ricks overruled the Motion for New Trial after considering the briefs, arguments of counsel contained therein, and relevant law.
The Federal Court date for Partial Summary Judgment is set in January 2005.
The Federal Magistrate Judge has ruled that a report and recommendation on whether a preliminary injunction should issue is not in the interests of judicial economy of the Federal Court, because the report and recommendation would most likely be finalized about the same time as the Partial Summary Judgment hearing date. Thus, the court will wait to rule on the preliminary injunction until the Motion for Summary Judgment is ruled upon and the Court considers and rules on Shinn Captial Group, Inc.'s Motion to Dismiss for Lack of Personal Jurisdiction. The Court has already denied Defendant Ronald Shinn and Defendant Gerry Knight's Motions to Dismiss.
We are fully confident in the judiciary and the legal process under which HTTD is proceeding.
HTTD is currently involved in litigation regarding the rights to Tubercin(R). Additional information and details regarding the litigation can be viewed on our website at: http://www.htdsotc.com
Statements in this press release that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933, as amended. Those statements include statements regarding the intent, belief or current expectations of the Company and its management. Such statements reflect management's current views, are based on certain assumptions and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, our ability to obtain additional financing and access funds from our existing financing arrangements that will allow us to continue our current and future operations and whether demand for our product and testing service in domestic and international markets will continue to expand. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company's expectations with regard to these forward-looking statements or the occurrence of unanticipated events.